Immunosuppressive drug use in pregnancy

Autoimmunity

Volumn 36, Issue 1, 2003, Pages 51-56

  Petri, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Azathioprine; Pregnancy; Steroids; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MEPACRINE; MESNA; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADRENAL SUPPRESSION; ANTIPHOSPHOLIPID SYNDROME; BIRTH DEFECT; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; BONE NECROSIS; BREAST FEEDING; CARCINOGENESIS; CATARACT; CLEFT PALATE; CLINICAL TRIAL; CONGENITAL CATARACT; CONGENITAL HEART BLOCK; CONGENITAL MALFORMATION; CONNECTIVE TISSUE DISEASE; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DISCOID LUPUS ERYTHEMATOSUS; DISEASE CONTROL; DISEASE EXACERBATION; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG MEGADOSE; DRUG METABOLISM; DRUG MILK LEVEL; DRUG MONITORING; DRUG PENETRATION; DRUG SAFETY; DRUG TISSUE LEVEL; FETUS DISEASE; HEMORRHAGIC CYSTITIS; HEPATITIS; HUMAN; HYPERTENSION; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRAUTERINE GROWTH RETARDATION; LEUKOPENIA; LIVER FUNCTION TEST; LONG TERM EXPOSURE; MALARIA; MATERNAL HYPERTENSION; MATERNAL TREATMENT; MOTHER FETUS RELATIONSHIP; MUTAGENESIS; NEPHROTOXICITY; NEWBORN INFECTION; NONHUMAN; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PANCYTOPENIA; PLACENTAL TRANSFER; PLASMAPHERESIS; POSTMARKETING SURVEILLANCE; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PREMATURE OVARIAN FAILURE; PRENATAL DRUG EXPOSURE; PROTECTION; RETINA DEGENERATION; REVIEW; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENESIS; THROMBOCYTOPENIA; TOXICITY TESTING; VASCULITIS;

ADRENAL CORTEX HORMONES; AZATHIOPRINE; BREAST FEEDING; CYCLOPHOSPHAMIDE; CYCLOSPORINE; FEMALE; FETAL DISEASES; HUMANS; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATERNAL-FETAL EXCHANGE; MYCOPHENOLIC ACID; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0037297707     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/0891693031000067296     Document Type: Review

References (105)

1. Petri, M., Howard, D. and Repke, J. (1991) "Frequency of lupus flare in pregnancy: The Hopkins Lupus Pregnancy Center experience", Arthritis Rheum. 34, 1538-1545.
2. Ruiz-Irastorza, G., Lima, F., Alves, J., Khamashta, M.A., Simpson, J., Hughes, G.R. and Buchanan, N.M. (1996) "Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies", Br. J. Rheumatol. 35(2), 133-138.
3. Laskin, C.A., Bombardier, C., Hannah, M.E., Mandel, F.P., Ritchie, J.W.K., Farewell, V., Farine, D., Spitzer, K., Fielding, L., Solininka, C.A. and Yeung, M. (1997) "Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss", N. Engl. J. Med. 337, 148-153.
4. Rider, L.G., Buyon, J.P., Rutledge, J. and Sherry, D. (1993) "Treatment of neonatal lupus: Case report and review of the literature", J. Rheumatol. 20, 1208-1211.
5. Carreira, P.E., Gutierrez-Larraya, F. and Gomez-Reino, J.J. (1993) "Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus", J. Rheumatol. 20, 1204-1207.
6. Petri, M. (1994) "Systemic lupus erythematosus and pregnancy", Rheum. Dis. Clin. N. Am. 20, 87-118.
7. Cowchock, F.S., Reece, E.A., Balaban, D., Branch, D.W. and Plouffe, L. (1993) "Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment", Am. J. Obstet. Gynecol. 166, 1318-1323.
8. Silver, R.K., MacGregor, S.N., Sholl, J.S., Hobart, J.M., Neerhof, M.G. and Ragin, A. (1993) "Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients", Am. J. Obstet. Gynecol. 169(6), 1411-1417.
9. Blanford, A.T. and Murphy, B.P. (1977) "In vitro metabolism of prednisone, dexamethasone, and cortisol by the human placenta", Am. J. Obstet. Gynecol. 127, 264-267.
10. Anderson, G.G., Rotchell, Y. and Kaiser, D.G. (1981) "Placental transfer of methylprednisolone following maternal intravenous administration", Am. J. Obstet. Gynecol. 140, 699-701.
11. Lockshin, M.D. and Sammaritano, L.R. (1998) "Corticosteroids during pregnancy", Scand. J. Rheumatol. Suppl. 107, 136-138.
12. Rayburn, W.F. (1992) "Glucocorticoid therapy for rheumatic diseases: Maternal, fetal, and breast-feeding considerations", Am. J. Reprod. Immunol. 28(3-4), 138-140.
13. Bongiovanni, A.M. and McPadden, A.J. (1960) "Steroids during pregnancy and possible fetal consequences", Fertil. Steril. 11, 181-186.
14. Cote, C.J., Meuwissen, J. and Picketing, R. (1974) "Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy", J. Pediatr. 85, 324-328.
15. Cederqvist, L., Merkatz, I. and Litwin, S. (1977) "Fetal immunoglobulin synthesis following maternal immunosuppression", Am. J. Obstet. Gynecol. 129, 687-690.
16. Kraus, A.M. (1975) "Congenital cataract and maternal steroid injection", J. Pediatr. Ophthalmol. 12, 107-108.
17. Reinisch, J.M., Simon, N.G., Karow, W.G. and Gandelman, R. (1978) "Prenatal exposure to prednisone in humans and animals retards intrauterine growth", Science 202, 436-438.
18. Scott, J. (1977) "Fetal growth retardation associated with maternal administration of immunosuppressive drugs", Am. J. Obstet. Gynecol. 128, 668-676.
19. Out, H.J., Bruinse, H.W., Christiaens, G.C., Van Vliet, M., De Groot, P.G., Nieuwenhuis, H.K., et al. (1992) "A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies", Am. J. Obstet. Gynecol. 167(1), 26-32.
20. Mintz, G., Niz, J., Gutierrez, C., Garcia-Alonso, A. and Karchmer, S. (1986) "Prospective study of pregnancy in systemic lupus erythematosus: Results of a multidisciplinary approach", J. Rheumatol. 13, 732-739.
21. Logaridis, T.E., Doran, T.A., Scott, J.G. and Gare, D.G. and Comtesse, C. (1983) "The effect of maternal steroid administration on fetal platelet count in immunologic thrombocytopenic purpura", Am. J. Obstet. Gynecol. 145, 147-151.
22. Sermant, H., Charpin, J., Tessier, G., et al. (1968) "Corticotherapie et grossesse", Bull. Fed. Soc. Gynecol. Obstet. Franc. 20, 159-161.
23. Heinonen, O.P., Slone, D. and Shapiro, S. (1977) Birth Defects and Drugs in Pregnancy (Publishing Science Group, Littleton, MA).
24. Houser, M.T., Fish, A.J., Tagatz, G.E., Williams, P.P. and Michael, A.F. (1980) "Pregnancy and systemic lupus erythematosus", Am. J. Obstet. Gynecol. 138, 409-413.
25. Zulman, J.I., Talal, N., Hoffman, G.S. and Epstein, W.V. (1980) "Problems associated with the management of pregnancies in patients with systemic lupus erythematosus", J. Rheumatol. 7, 37-49.
26. Varner, M.W., Meehan, R.T., Syrop, C.H., Strottmann, M.P. and Goblerud, C.P. (1983) "Pregnancy in patients with systemic lupus erythematosus", Am. J. Obstet. Gynecol. 145, 1025-1040.
27. Lubbe, W.F., Butler, W.S., Palmer, S.J. and Liggins, G.C. (1983) "Fetal survival after prednisone suppression of maternal lupus anticoagulant", Lancet 1, 1361-1363.
28. Lockshin, M.D., Reinitz, E., Druzin, M.L., Murrman, M. and Estes, D. (1984) "Lupus pregnancy I. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy", Am. J. Med. 77, 893-898.
29. Committee on Drugs, American Academy of Pediatrics (1989) "The transfer of drugs and other chemicals into human breast milk", Pediatrics 84, 924-936.
30. Ost, L., Wettrell, G., Bjorkhem, I. and Rane, A. (1985) "Prednisolone excretion in human milk", J. Pediatr. 106, 1008-1011.
31. Fox, R.I. (1993) "Mechanism of action of hydroxychloroquine as an antirheumatic drug", Semin. Arthritis Rheum. 23(Suppl. 1), 82-91.
32. Wolfe, M. and Cordero, J. (1985) "Safety of chloroquine in chemosuppression of malaria during pregnancy", Br. Med. J. 290, 1446-1447.
33. (1983) "Malaria in pregnancy", Lancet 2(July, 8341), 84-85.
34. McCarty, G.A., personal communication.
35. Tsakonas, E., Joseph, L., Esdaile, J.M., Choquette, D., Senecal, J.L., Cividino, A., Danoff, D., Osterland, C.K., Yeadon, C. and Smith, C.D. (1998) "A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group", Lupus 7, 80-85.
36. Borden, M.B. and Parke, A.L. (2001) "Antimalarial drugs in systemic lupus erythematosus: Use in pregnancy", Drug Saf. 24(14), 1055-1063.
37. McChesney, E.W. (1983) "Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate", Am. J. Med. 75(1A), 11-18.
38. Ullberg, S., Lindquist, N. and Sjostrand, S. (1970) "Accumulation of chorioretinotoxic drugs in the foetal eye", Nature 227, 1257-1258.
39. Fail, P.A., Martin, P. and Sokal, D. (2000) "Comparative effects of quinacrine and erythromycin in adult female rats: A nonsurgical sterilization study", Fertil. Steril. 73, 387-394.
40. Hart, C. and Naunton, R. (1964) "The ototoxicity of chloroquine phosphate", Arch. Otolaryngol. Head Neck Surg. 80, 407-412.
41. Panfique, L. and Magnard, P. (1969) "Retinal degeneration in 2 children following preventive antimalarial treatment of mother during pregnancy", Bull. Soc. Ophthalmol. Fr. 69, 466-467.
42. Levy, M., Buskila, D., Gladman, D.D., Urowitz, M.B. and Koren, G. (1991) "Pregnancy outcome following first trimester exposure to chloroquine", Am. J. Perinatol. 8, 174-178.
43. Buchanan, N.M.M., Toubi, E., Khamashta, M.A., Lima, F., Kerslake, S. and Hughes, G.R.V. (1996) "Hydroxychloroquine and lupus pregnancy: Review of a series of 36 cases", Ann. Rheum. Dis. 55, 486-488.
44. Parke, A. and West, B. (1996) "Hydroxychloroquine in pregnant patients with systemic lupus erythematosus", J. Rheumatol. 23, 1715-1718.
45. Levy, R.A., Vilela, V.S., Cataldo, M.J., Ramos, R.C., Duarte, J.L., Tura, B.R., Albuquerque, E.M. and Jesus, N.R. (2001) "Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebo-controlled study", Lupus 10, 401-404.
46. Briggs, G.G., Freeman, R.K., Yaffe, S.J., eds, (1990) Drugs in Pregnancy and Lactation, 3rd ed. (Williams and Wilkins, Baltimore).
47. Penn, I., Makowski, E. and Harris, P. (1980) "Parenthood following renal transplantation", Kidney Int. 18, 221-233.
48. Pirson, Y., Van Lierde, M., Ghysen, J., Squifflet, J.P., Alexandre, G.P.J. and Van Ypersele De Strihou, C. (1985) "Retardation of fetal growth in patients receiving immunosuppressive therapy [letter] N. Engl. J. Med. 313, 328.
49. Report from the Registration Committee of the European Dialysis and Transplant Association (1980) "Successful pregnancies in women treated by dialysis and kidney transplantation", Br. J. Obstet. Gynaecol. 87, 839-845.
50. Davison, J.M. and Lindheimer, M.D. (1982) "Pregnancy in renal transplant recipients", J. Reprod. Med. 27, 613-621.
51. Marushak, A., Weber, T., Bock, J., Birkeland, S.A., Hansen, H.E., Klebe, J., Kristoffersen, K., Rasmussen, K. and Olgaard, K. (1986) "Pregnancy following kidney transplantation", Acta Obstet. Gynecol. Scand. 65, 557-559.
52. Rudolph, J., Schweizer, R. and Bartus, S. (1979) "Pregnancy in renal transplant patients", Transplantation 27, 36-39.
53. Hadi, H.A., Stafford, C.R., Williamson, J.R., Fadel, H.E. and Devoe, L.D. (1986) "Pregnancy outcome in renal transplant recipients", South Med. J. 79, 959-964.
54. Registration Committee of the European Dialysis and Transplant Association (1980) "Successful pregnancies in women treated by dialysis and kidney transplantation", Br. J. Obstet. Gynaecol. 87, 839-845.
55. Meehan, R.T. and Dorsey, J.K. (1987) "Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy", J. Rheumatol. 14, 252-258.
56. Ramsey-Goldman, R., Mientus, J.M., Kutzer, J.E., Mulvihill, J.J. and Medsger, Jr., T.A. (1993) "Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs", J. Rheumatol. 20, 1152-1157.
57. Martinez-Rueda, O., Arce-Salinas, A., Kraus, A., et al. (1993) "Factors associated with fetal wastage in 73 pregnancies of women with severe lupus [abstract] Arthritis Rheum. 36(Suppl.), S74.
58. Leb, D., Weisskopf, B. and Kanovitz, B. (1971) "Chromosome aberrations in the child of a kidney transplant recipient", Arch. Intern. Med. 128, 441-444.
59. Davison, J.M., Dellagrammatikas, H. and Parkin, J.M. (1985) "Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients", Br. J. Obstet. Gynaecol. 92, 233-239.
60. Lower, G.D., Stevens, L.E., Najarian, J.S. and Reemtsma, K. (1971) "Problems from immunosuppressives during pregnancy", Am. J. Obstet. Gynecol. 111, 1120-1121.
61. Price, H.V., Salaman, J.R., Laurence, K.M. and Langmaid, H. (1976) "Immunosuppressive drugs and the fetus", Transplantation 21, 294-298.
62. DeWitte, D.B., Buick, M.K., Cyran, S.E. and Maisels, M.J. (1984) "Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone", J. Pediatr. 105, 625-628.
63. Roubenoff, R., Hoyt, M., Petri, M., Hochberg, M. and Hellmann, D. (1988) "Effects of antiinflammatory and immunosuppresive drugs on pregnancy and fertility", Semin. Arthritis Rheum. 18, 88-110.
64. Coulam, C.B., Moyer, T.P., Jiang, N.S. and Zincke, H. (1982) "Breast-feeding after renal transplantation", Transplant. Proc. 14, 605-609.
65. Chan, T.M., Li, F.K., Tang, C.S., Wong, R.W., Fang, G.X., Ji, Y.L., Lau, C.S., Wong, A.K., Tong, M.K., Chan, K.W. and Lai, K.N. (2000) "Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group", N. Engl. J. Med. 343(16), 1156-1162.
66. Ines, L.S. and Petri, M. (2001) "Mycophenolate mofetil: An emerging therapeutic option for systemic lupus erythematosus", Acta Reumatologica Portuguesa 26, 153-162.
67. Investigators Brochure Ro 106-1443: Roche; 2001 July. Report No., 1005391.
68. Hussein, M.M., Mooij, J.M.V. and Roujouleh, H. (1993) "Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy", Clin. Nephrol. 40, 160-163.
69. Favre, H., et al. (1989) "Cyclosporin in the treatment of lupus nephritis", Am. J. Nephrol. 9(Suppl. 1), 57-60.
70. Feutren, G., Querin, S., Tron, F., et al. (1986) "The effects of cyclosporine in patients with systemic lupus erythematosus", Transplant. Proc. 18, 634-644.
71. Winter, H., Mackenzie, W.E. and Newton, J.R. (1990) "Successful pregnancy following liver transplantation in a patient taking cyclosporine A", J. Obstet. Gynaecol. 10, 396-397.
72. Flechner, S.M., Katz, A.R., Rogers, A.J., Van Buren, C. and Kahan, B.D. (1985) "The presence of cyclosporine in body tissues and fluids during pregnancy", Am. J. Kidney Dis. 5, 60-63.
73. Klintmalm, G., Althoff, P., Appleby, G. and Segerbrandt, E. (1984) "Renal function in a newborn baby delivered of a renal transplant patients taking cyclosporine", Transplantation 38, 98-99.
74. Grischke, E., Kaufmann, M., Dreikorn, K., Linderkamp, O. and Kubli, F. (1986) "Erfolgreiche schwangerschaft bei nierentransplantation und cyclosporin A", Geburtsh u. Grauenheilk 46, 176-179.
75. Endler, M., Derfler, K., Schaller, A. and Nowotny, C. (1987) "Schwangerschaft und geburt nach nierentransplantation unter cyclosporin A", Geburtsh u. Grauenheilk 47, 660-663.
76. Bourget, P., Fernandez, H. and Delouis, C. (1991) "Accumulation of cyclosporine in the conceptus during the first trimester of pregnancy after liver transplantation", Transplantation 51, 1306-1307.
77. Cockburn, I., Krupp, P. and Monka, C. (1989) "Present experience of Sandimmune in pregnancy", Transplant. Proc. 21, 3730-3732.
78. Hou, S. (1989) "Pregnancy in organ transplant recipients", Med. Clin. N. Am. 73, 667-683.
79. Haugen, G., Fauchald, P., Sodal, G., Halvorsen, S., Oldereid, N. and Moe, N. (1991) "Pregnancy outcome in renal allograft recipients: Influence of cyclosporin A", Eur. J. Obstet. Gynecol. Reprod. Biol. 39, 25-29.
80. Arellano, F., Monka, C. and Krupp, P. (1991) "Tratamiento con ciclosporina A en la gestante [letter]", Med. Clin. (Barc.) 96, 194.
81. Pickrell, M.D. and Sawers, R. (1988) "Pregnancy after renal transplantation: Severe intrauterine growth retardation during treatment with cyclosporine A [letter]", Br. Med. J. 296, 825.
82. Muirhead, N., Sabharwal, A.R., Rieder, M.J., Lazarovits, A.I. and Hollomby, D.J. (1992) "The outcome of pregnancy following renal transplantation - The experience of a single center", Transplantation 54, 429-432.
83. Ostensen, M. (1992) "Treatment with immunosuppressive and disease modifying drugs during pregnancy and lactation", Am. J. Reprod. Immunol. 28(3-4), 148-152.
84. Imbasciati, E. and Ponticelli, C. (1991) "Pregnancy and renal disease: Predictors for fetal and maternal outcome", Am. J. Nephrol. 11, 353-362.
85. Pujals, J.M., Figueras, G. and Puig, J.M. (1989) "Osseous malformation in baby born to woman on cyclosporin [letter]", Lancet 1, 667.
86. Takahashi, N., Nishida, H. and Hoshi, J. (1994) "Severe B-cell depletion in newborns from renal transplant mothers taking immunosuppressive agents", Transplantation 57, 1617-1621.
87. Rose, M.L., Dominguez, M., Leaver, N., Lachno, R. and Yacoub, M.H. (1989) "Analysis of T-cell subpopulations and cyclosporine levels in the blood of two neonates born to immunosuppressed heart-lung transplant recipients", Transplantation 48, 223-226.
88. American Academy of Pediatrics Committee on Drugs (1989) "Transfer of drugs and other chemicals into human milk", Pediatrics 84, 924-936.
89. Boumpas, D.T., Austin, III, H.A., Vaughan, E.M., Yarboro, C.H., Klippel, J.H. and Balow, J.E. (1993) "Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy", Ann. Intern. Med. 119, 366-369.
90. Radis, C.D., Kahl, L.E., Baker, G.L., Wasko, M.C., Cash, J.M., Gallatin, A., Stolzer, B.L., Agarwal, A.K., Medsger, T.A., Jr. and Kwoh, C.K. (1995) "Effects of cyclophosphoamide on the development of malignancy and on the long-term survival of patients with rheumatoid arthritis: A 20-year followup study", Arthritis Rheum. 38, 1120-1127.
91. D' Incalci, M., Senssa, C., Columbo, N., De Palo, G., Semprini, A.E. and Pardi, G. (1982) "Transplacental passage of cyclophosphamide", Cancer Treat. Rep. 66, 1681-1682.
92. Greenberg, L.H. and Tanaka, K.R. (1964) "Congenital anomalies probably induced by cyclophosphamide", JAMA 188, 423-426.
93. Kirshon, B., Wasserstrum, N., Willis, R., Herman, G.E. and McCabe, E.R.B. (1988) "Teratogenic effects of 1st-trimester cyclophosphamide therapy", Obstet. Gynecol. 72, 462-464.
94. Murray, C.L., Reichert, J.A., Anderson, J. and Twiggs, L.B. (1984) "Multimodal cancer therapy for breast cancer in the first trimester of pregnancy", JAMA 252, 2607-2608.
95. Mutchinick, O., Aizpuru, E. and Grether, P. (1992) "The human teratogenic effect of cyclophosphamide", Aust. Teratog. Abs. 45, 329.
96. Toledo, T.M., Harper, R.C. and Moser, R.H. (1971) "Fetal effects during cyclophosphamide and irradiation therapy", Ann. Intern. Med. 74, 87-91.
97. Zemlickis, D., Lishner, M., Erlich, R. and Koren, G. (1993) "Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide", Teratog. Carcinog. Mutagen. 13, 139-143.
98. Enns, G.M., Roeder, E., Chan, R.T., Ali-Khan Catts, Z., Cox, V.A. and Golabi, M. (1999) "Apparent cyclophosphamide (cytoxan) embryopathy: A distinct phenotype?", Am. J. Med. Genet. 86(3), 237-241.
99. Durodola, J.I. (1979) "Administration of cyclophosphamide during late pregnancy and early lactation" A case report", J. Natl. Med. Assoc. 71, 165-166.
100. Haerr, R.W. and Pratt, A.T. (1985) "Multiagent chemotherapy for sarcoma diagnosed during pregnancy", Cancer 56, 1028-1033.
101. Nicholson, H.O. (1968) "Cytotoxic drugs in pregnancy: Review of reported cases", J. Obstet. Gynaecol. 75, 307-312.
102. Pizzuto, J., Aviles, A., Noriega, L., Niz, J., Morales, M. and Romero, F. (1980) "Treatment of acute leukemia during pregnancy: Presentation of nine cases", Cancer Treat. Rep. 64, 679-683.
103. Sanders, J.E., Hawley, J., Levy, W., Gooley, T., Buckner, C.D., Deeg, H.J., Doney, K., Storb, R., Sullivan, K., Witherspoon, R. and Appelbaum, F.R. (1996) "Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation", Blood 87, 3045-3052.
104. Sweet, D.L. and Kinzie, J. (1976) "Consequences of radiotherapy and antineoplastic therapy for the fetus", J. Reprod. Med. 17, 241-246.
105. Wiernik, P.H. and Duncan, J.H. (1971) "Cyclophosphamide in human milk", Lancet 1, 912.